immune therapeutics inc (IMUN:OTC US)
Ronald B. Herberman M.D.
Former Chief Medical Officer, Senior Vice President of Research & Development and Director of Medical Research & Development, Immune Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 5 different industries.|
As of Fiscal Year 2013
Mr. Ronald B. Herberman, M.D served as an Advisor of TNI Pharmaceuticals, Inc. Dr. Herberman served as Chief Medical Officer and Senior Vice President of Research & Development at TNI BioTech, Inc. since September 6, 2012 and served as its Director of Medical Research & Development. He served as the Chief Medical Officer of Oncology at Intrexon Corporation since September 1, 2009. Dr. Herberman served as a Director of Celsense, Inc. Dr. Herberman served as a Member of ...
37 North Orange AvenuePhone: 888-613-8802
Orlando, Florida 32801
Board Members Memberships*There is no Board Members Memberships data available.
NYU Elaine A. and Kenneth G. Langone Medical Center
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|John W. Varian||Chief Executive Officer and Director|
|Simon E. Moroney Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Charles G. Marianik||Chairman of the Board, Chief Executive Officer and President|
|David L. Hallal||Chief Executive Officer and Director|
Alexion Pharmaceuticals, Inc.
|$696.1K||Compensation as of Fiscal Year 2014.|